Compare $KAPA vs $VIVS | Chartloom

Compare

$KAPA vs $VIVS

Kairos Pharma Ltd · VivoSim Labs Inc

KAPA

Kairos Pharma Ltd

VIVS

VivoSim Labs Inc

Compare $KAPA vs $VIVS

Comparing Kairos Pharma Ltd and VivoSim Labs Inc

KAPAKairos Pharma Ltd

VIVSVivoSim Labs Inc

KAPAKairos Pharma Ltd

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.1%

52W performance

-91.2%

FCF yield

-22.9%

VIVSVivoSim Labs Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.1%

YTD performance

-90.4%

52W performance

-94.3%

FCF yield

-466.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KAPA

VIVS

Detailed metrics comparison

KAPA

Kairos Pharma Ltd

VIVS

VivoSim Labs Inc

Market Cap

KAPA$17M

VIVS$2M

Enterprise Value

KAPA$15M

VIVS$502K

Price

KAPA$0.81

VIVS$0.18

P/E Ratio

KAPAN/A

VIVSN/A

P/S Ratio

KAPA0.00x

VIVS19.39x

EV/Sales

KAPA0.00x

VIVS4.48x

EV/EBITDA

KAPA0.00x

VIVS0.00x

P/B Ratio

KAPA1.26x

VIVS0.73x

P/FCF Ratio

KAPAN/A

VIVSN/A

EV/FCF

KAPA-3.71x

VIVS-0.05x

PEG Ratio

KAPAN/A

VIVSN/A

Forward P/E (NTM)

KAPAN/A

VIVSN/A

Forward P/S (NTM)

KAPAN/A

VIVSN/A

Revenue (TTM)

KAPA$0

VIVS$112K

Revenue Growth (YoY)

KAPAN/A

VIVS-21.1%

Forward Rev Growth

KAPA0.0%

VIVS0.0%

Gross Margin (TTM)

KAPA0.0%

VIVS83.9%

Operating Margin (TTM)

KAPA0.0%

VIVS0.0%

EBITDA Margin (TTM)

KAPA0.0%

VIVS-9943.8%

Net Margin (TTM)

KAPA0.0%

VIVS-11016.1%

FCF Margin (TTM)

KAPAN/A

VIVS-9038.4%

Net Income (TTM)

KAPA$-6M

VIVS$-12M

FCF (TTM)

KAPA$-4M

VIVS$-10M

EPS (TTM)

KAPA-$0.27

VIVS-$2.35

ROE (TTM)

KAPA-9877.0%

VIVS-1556.0%

ROA (TTM)

KAPA-9361.0%

VIVS-17702.0%

ROIC (TTM)

KAPA-9877.0%

VIVS-1556.0%

Cash

KAPA$3M

VIVS$2M

Debt

KAPA$0

VIVS$0

Net Cash/Debt

KAPA$3M

VIVS$2M

Current Ratio (TTM)

KAPA11.98x

VIVS1.70x

Quick Ratio (TTM)

KAPA11.46x

VIVS1.43x

Debt/Equity (TTM)

KAPA0.00x

VIVS0.00x

Debt/Assets (TTM)

KAPA0.0%

VIVS0.0%

Interest Coverage (TTM)

KAPAN/A

VIVSN/A

Net Debt/EBITDA (TTM)

KAPA0.00x

VIVS0.00x

Beta

KAPA3.30

VIVS1.57

52W Performance

KAPA-91.2%

VIVS-94.3%

YTD Performance

KAPA-84.1%

VIVS-90.4%

% from 52W High

KAPA-91.6%

VIVS-94.9%

% from 52W Low

KAPA3.5%

VIVS7.2%

Asset Turnover (TTM)

KAPA0.00x

VIVS0.02x

FCF Yield (TTM)

KAPA-22.9%

VIVS-466.1%

Earnings Yield (TTM)

KAPA-33.5%

VIVS-568.0%

Dividend Yield (TTM)

KAPAN/A

VIVSN/A

Rule of 40

KAPA0.0

VIVS-9,059.5

EV/GP/RG

KAPAN/A

VIVSN/A

Ticker research

View KAPA research View VIVS research

Metric	KAPA Kairos Pharma Ltd	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$17M	$2M
Enterprise Value	$15M	$502K
Price	$0.81	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	19.39x
EV/Sales	0.00x	4.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.26x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.71x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$112K
Revenue Growth (YoY)	N/A	-21.1%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-9943.8%
Net Margin (TTM)	0.0%	-11016.1%
FCF Margin (TTM)	N/A	-9038.4%
Net Income (TTM)	$-6M	$-12M
FCF (TTM)	$-4M	$-10M
EPS (TTM)	-$0.27	-$2.35
ROE (TTM)	-9877.0%	-1556.0%
ROA (TTM)	-9361.0%	-17702.0%
ROIC (TTM)	-9877.0%	-1556.0%
Financial Health
Cash	$3M	$2M
Debt	$0	$0
Net Cash/Debt	$3M	$2M
Current Ratio (TTM)	11.98x	1.70x
Quick Ratio (TTM)	11.46x	1.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.30	1.57
52W Performance	-91.2%	-94.3%
YTD Performance	-84.1%	-90.4%
% from 52W High	-91.6%	-94.9%
% from 52W Low	3.5%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-22.9%	-466.1%
Earnings Yield (TTM)	-33.5%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-9,059.5
EV/GP/RG	N/A	N/A
Ticker research	View KAPA research	View VIVS research

Valuation

P/S Ratio

KAPA

0.00x

VIVS

19.39x

EV/FCF

KAPA

-3.71x

VIVS

-0.05x

Growth & revenue

Revenue Growth TTM

VIVS

-21.1%

Forward Revenue Growth

KAPA

0.0%

VIVS

0.0%

Profitability & performance

Gross Margin

VIVS

83.9%

KAPA

0.0%

ROE

VIVS

-1556.0%

KAPA

-9877.0%

FCF Yield %

KAPA

-22.9%

VIVS

-466.1%

52-Week Performance

KAPA

-91.2%

VIVS

-94.3%

Detailed metrics comparison

KAPA

Kairos Pharma Ltd

VIVS

VivoSim Labs Inc

Market Cap

KAPA$17M

VIVS$2M

Enterprise Value

KAPA$15M

VIVS$502K

Price

KAPA$0.81

VIVS$0.18

P/E Ratio

KAPAN/A

VIVSN/A

P/S Ratio

KAPA0.00x

VIVS19.39x

EV/Sales

KAPA0.00x

VIVS4.48x

EV/EBITDA

KAPA0.00x

VIVS0.00x

P/B Ratio

KAPA1.26x

VIVS0.73x

P/FCF Ratio

KAPAN/A

VIVSN/A

EV/FCF

KAPA-3.71x

VIVS-0.05x

PEG Ratio

KAPAN/A

VIVSN/A

Forward P/E (NTM)

KAPAN/A

VIVSN/A

Forward P/S (NTM)

KAPAN/A

VIVSN/A

Revenue (TTM)

KAPA$0

VIVS$112K

Revenue Growth (YoY)

KAPAN/A

VIVS-21.1%

Forward Rev Growth

KAPA0.0%

VIVS0.0%

Gross Margin (TTM)

KAPA0.0%

VIVS83.9%

Operating Margin (TTM)

KAPA0.0%

VIVS0.0%

EBITDA Margin (TTM)

KAPA0.0%

VIVS-9943.8%

Net Margin (TTM)

KAPA0.0%

VIVS-11016.1%

FCF Margin (TTM)

KAPAN/A

VIVS-9038.4%

Net Income (TTM)

KAPA$-6M

VIVS$-12M

FCF (TTM)

KAPA$-4M

VIVS$-10M

EPS (TTM)

KAPA-$0.27

VIVS-$2.35

ROE (TTM)

KAPA-9877.0%

VIVS-1556.0%

ROA (TTM)

KAPA-9361.0%

VIVS-17702.0%

ROIC (TTM)

KAPA-9877.0%

VIVS-1556.0%

Cash

KAPA$3M

VIVS$2M

Debt

KAPA$0

VIVS$0

Net Cash/Debt

KAPA$3M

VIVS$2M

Current Ratio (TTM)

KAPA11.98x

VIVS1.70x

Quick Ratio (TTM)

KAPA11.46x

VIVS1.43x

Debt/Equity (TTM)

KAPA0.00x

VIVS0.00x

Debt/Assets (TTM)

KAPA0.0%

VIVS0.0%

Interest Coverage (TTM)

KAPAN/A

VIVSN/A

Net Debt/EBITDA (TTM)

KAPA0.00x

VIVS0.00x

Beta

KAPA3.30

VIVS1.57

52W Performance

KAPA-91.2%

VIVS-94.3%

YTD Performance

KAPA-84.1%

VIVS-90.4%

% from 52W High

KAPA-91.6%

VIVS-94.9%

% from 52W Low

KAPA3.5%

VIVS7.2%

Asset Turnover (TTM)

KAPA0.00x

VIVS0.02x

FCF Yield (TTM)

KAPA-22.9%

VIVS-466.1%

Earnings Yield (TTM)

KAPA-33.5%

VIVS-568.0%

Dividend Yield (TTM)

KAPAN/A

VIVSN/A

Rule of 40

KAPA0.0

VIVS-9,059.5

EV/GP/RG

KAPAN/A

VIVSN/A

Ticker research

View KAPA research View VIVS research

Metric	KAPA Kairos Pharma Ltd	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$17M	$2M
Enterprise Value	$15M	$502K
Price	$0.81	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	19.39x
EV/Sales	0.00x	4.48x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.26x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.71x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$112K
Revenue Growth (YoY)	N/A	-21.1%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-9943.8%
Net Margin (TTM)	0.0%	-11016.1%
FCF Margin (TTM)	N/A	-9038.4%
Net Income (TTM)	$-6M	$-12M
FCF (TTM)	$-4M	$-10M
EPS (TTM)	-$0.27	-$2.35
ROE (TTM)	-9877.0%	-1556.0%
ROA (TTM)	-9361.0%	-17702.0%
ROIC (TTM)	-9877.0%	-1556.0%
Financial Health
Cash	$3M	$2M
Debt	$0	$0
Net Cash/Debt	$3M	$2M
Current Ratio (TTM)	11.98x	1.70x
Quick Ratio (TTM)	11.46x	1.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.30	1.57
52W Performance	-91.2%	-94.3%
YTD Performance	-84.1%	-90.4%
% from 52W High	-91.6%	-94.9%
% from 52W Low	3.5%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-22.9%	-466.1%
Earnings Yield (TTM)	-33.5%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-9,059.5
EV/GP/RG	N/A	N/A
Ticker research	View KAPA research	View VIVS research